Clinical Trials (PDQ®) - National Cancer Institute

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp online chat

	NCI Highlights


	Maintenance Rituximab for Follicular Lymphoma Azacitidine Improves Survival in MDS Second Stem Cell Transplant Not Helpful in Myeloma

	Related Links


	Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

Efficacy of an Oral Formula in Prevention of Anti-Cancer Therapy Side Effects

Basic Trial Information
Trial Description
Summary
Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs
Phase III Supportive care Active Over 18 Other 06.23.CLI
NCT00455247

Trial Description

Summary

Anti-cancer treatment is often inducing side-effects that can affect the compliance to the treatment protocol and quality of life of the patients. The researchers will study if the nutritional intervention with the product could abrogate the undesired effects in a preventive manner.

Eligibility Criteria

Inclusion Criteria:

Patient with GI neoplasm

Newly diagnosed cancer patient that should undergo anti-cancer treatment or patient that should undergo a new anti-cancer treatment

Age > 18 ans

Orally fed

Having obtained his/her informed consent

Life expectancy more than 3 months

Exclusion Criteria:

Positive HIV status

Pregnant or lactating woman

Currently participating or having participated in another clinical trial during the last prior 1 month to the beginning of this study

Patient regularly having diarrhoea before inclusion

State of sub occlusion, chronic inflammatory diseases of the digestive tract, radiation enteropathy

Sepsis

Trial Contact Information

Trial Lead Organizations/Sponsors

Nestle Nutrition

Pierre SENESSE, MD

Principal Investigator

Pierre SENESSE, MD		Ph: +33 4 67 61 85 54
		Email: psenesse@valdorel.fnclcc.fr

Trial Sites

France

Lyon

CRLCC Léon Bérard

Montpellier

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00455247
Information obtained from ClinicalTrials.gov on March 18, 2009

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.